Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - NET INCOME
Net Income OCX - OncoCyte Corporation
-27.8 M
LAST VALUE
34.17%
2 YEAR CAGR
-12.01%
5 YEAR CAGR
-23.04%
10 YEAR CAGR